Program Overview

Program Overview

Friday, June 22, 2018 - Liver Cancer 1

  • Symposium on image guided therapy in oncology
    • Constructive model and strategy of cancer treatment
    • Updates on radiofrequency ablation and emerging techniques
    • Microwave ablation for large tumors
    • Case demonstrations: Percutaneous microwave ablation of complex liver tumors
    • Case demonstrations (video show): US-guided RFA of HCC with Artificial Ascites: How I do it
    • Microwave ablation technology for HCC: State of the art and development trends
  • Tea Break
  • Symposium on treatment for hepatocellular carcinoma (1)
    • Angio-architecture and hemodynamic in HCC – implications in the technique and principles of transarterial treatment for HCC
    • Lipiodol-based TACE for HCC – Rationale, technique and outcome
    • Conventional TACE for patients with portal vein tumor invasion
    • Transarterial treatment for large HCC >10cm
    • Panel discussion
  • Lunch Symposium
  • APSCVIR meets APAITO
    • Transarterial chemosaturation in the management of liver metastasis: technical innovations and outcome optimization
    • Accessory devices and techniques that enhance transarterial treatment for liver cancers
    • Radioembolization – Clinical indications and latest evidence
    • Dosimetry and treatment planning for radioembolization
    • Ablative chemoembolization for HCC
    • Panel discussion
  • Tea Break
  • Symposium on advanced image guidance for interventional oncology
    • Precision ablation of large tumors using 3-Dimensional visualization platform
    • Precise X ray guidance with I-Guide system for percutaneous access of lung tumors
    • Application of new image guidance technique in ablative and transarterial tumor treatment
    • Next generation intervention with seamless integration of Angio, CT and MR
    • Panel discussion
  • Gala Dinner

Saturday, June 23, 2018 - Pancreatic cancer, Liver cancer 2

  • Epidemiology and diagnosis of hepatocellular carcinoma
    • Epidemiology and management guidelines of HCC
    • Imaging diagnosis of liver cancers – The role of MRI with liver specific contrast
  • SIO meets APAITO (I)
    Emerging options and new treatment concepts in interventional oncology
    • Transradial approach for transarterial treatment of cancers
    • A new concept of tumor ablation for HCC
    • Emerging options and new treatment concepts in interventional oncology
    • Panel discussion
  • Tea Break
  • Symposium on treatment for hepatocellular carcinoma (2)
    • Techniques of superselective catheterization for transarterial treatment of HCC
    • Case demonstrations (video show): Techniques of superselective catheterization for transarterial treatment of HCC
    • Downstaging of HCC using DEB TACE
    • What are the differences between resin-based and glass based radioembolization
    • The ABC of immunotherapy and combination immunotherapy for HCC
  • Techniques of superselective hepatic artery catheterization
    • Techniques of superselective catheterization for transarterial treatment of HCC
    • Case demonstrations (video show): Techniques of superselective catheterization for transarterial treatment of HCC
  • Opening Ceremony
  • Lunch Symposium
  • Irreversible electroporation for pancreatic cancer (1)
    • Updates on the surgical management of pancreatic cancer
    • The current status and role of medical oncology in advanced pancreatic cancer
    • Advances in the science and clinical application of irreversible electroporation (IRE) in pancreatic cancer
    • Technical considerations and pitfalls in percutaneous IRE for pancreatic cancer
  • Tea Break
  • SIO meets APAITO (II)
    Irreversible electroporation for pancreatic cancer (2)
    • Case selection, technical advances and results of percutaneous IRE for pancreatic cancer
    • Limitations, technical pitfalls and complications of percutaneous IRE for pancreatic cancer
    • Panel discussion

Sunday, June 24, 2018 - Thyroid, breast, lung, brain, and renal cancer

  • Case demonstrations (video show) of irreversible electroporation for pancreatic cancer
    • Percutaneous IRE for pancreatic cancer
    • Percutaneous IRE for pancreatic cancer
  • Radiofrequency ablation of thyroid cancer
    • Technical advances of radiofrequency ablation for malignant thyroid lesions
    • Clinical outcome and complications of radiofrequency ablation of malignant thyroid lesions
    • Case demonstration (video show): RFA for malignant thyroid lesions
  • Tea Break
  • Loco-regional therapy for other cancers 1
    • Risk factors for Local Progression after Percutaneous Ablation of Lung Tumors
    • Radioactive seeds for treatment of metastatic brain tumor and malignant glioma: Technical considerations and outcomes
    • Case demonstration (video show): Radioactive seeds for treatment of metastatic brain tumor and malignant glioma
  • Lunch Symposium
  • Loco-regional therapy for other cancers 2
    • Percutaneous microwave ablation for renal cancer: Technical considerations and outcomes
    • Case demonstrations (video show): Percutaneous microwave ablation of complex renal tumor
    • Overview of cryoablation in interventional oncology

Whilst every attempt has been made to ensure that all aspects of the Conference announced will take place as scheduled, the Organising Committee reserves the right to make changes at any time should the need arises.


There are no products to list in this category.